Good News, Bad News … Biotech

When Price Action Heads South

One of the first things a professional (mentor) will teach aspiring traders, is:

‘Big money potential is on the downside’.

A famous example of this, was during the Panic of 1907,

Jesse Livermore raised capital by hawking his car for $5,000 (according to Wyckoff), then shorted the market.

Near the bottom on (or about) October 24th, 1907, he covered; netting over $1 million in profits.

That Was Then … Is That Now?

Well, conditions change, but human behavior does not.

Back in the day, it was newspapers, telephone, telegraph and ‘rumors’; today, we have Cramer 🙂

You’ll have to judge for yourself if the posts on this site are providing worthwhile insight.

Let’s move on to Biotech, SPBIO.

Since I am short this sector via LABD (not advice, not a recommendation), we’re going to look at that vehicle.

Biotech Leveraged Inverse LABD, Daily

After the entry on 9/14, at 16.99, price action has not looked back.

Note, the entry had a very tight stop as covered here.

The ‘risk’ is determined as the distance from entry to stop; in the case above, 16.99 – 16.66 = 0.33-pts.

For example, a ‘risk’ of $1,000 let’s say, equates to a position size just over 3,000 shares LABD (not advice, not a recommendation).

Trending

The chart shows LABD, is currently trending higher at an aggressive rate.

There’s no guarantee this will continue to hold.

However, at the same time, there’s been no ‘news generating’ breakout, either.

So, at this point, it’s all under the radar.

Bad News Comes Out

When price action heads south, bad news comes out.

On a daily basis now, with articles like this and this.

Positioning

The initial position has already been discussed.

Other minor ones have been opened but the more important part, is Stop placement.

The initial Stop has been moved from LABD 16.66 to yesterday’s low of LABD 17.59 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

The Danger Point®, trade mark: No. 6,505,279